Replication trial of omega ‐3s shows no effect in preventing psychosis

A randomized clinical trial involving more than 300 patients has found no benefit from omega‐3 polyunsaturated fatty acids in conjunction with cognitive therapy in preventing onset of psychotic illness in at‐risk young adults. The trial, results of which were published online Nov. 23, 2016, in JAMA Psychiatry, failed to replicate results of an earlier study indicating that omega‐3s were superior to placebo in reducing the risk of transition to psychosis.
Source: The Brown University Psychopharmacology Update - Category: Psychiatry Tags: Alternative Treatments Source Type: research